Harrow Ebit vs Tax Provision Analysis
HROW Stock | USD 10.38 0.26 2.44% |
Harrow Health financial indicator trend analysis is much more than just examining Harrow Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harrow Health is a good investment. Please check the relationship between Harrow Health Ebit and its Tax Provision accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.
Ebit vs Tax Provision
Ebit vs Tax Provision Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harrow Health Ebit account and Tax Provision. At this time, the significance of the direction appears to have strong relationship.
The correlation between Harrow Health's Ebit and Tax Provision is 0.69. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Harrow Health, assuming nothing else is changed. The correlation between historical values of Harrow Health's Ebit and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Harrow Health are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Ebit i.e., Harrow Health's Ebit and Tax Provision go up and down completely randomly.
Correlation Coefficient | 0.69 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Ebit
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most indicators from Harrow Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 736 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.73 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 54.3M | 63.2M | 90.6M | 95.1M | Total Revenue | 72.5M | 88.6M | 130.2M | 136.7M |
Harrow Health fundamental ratios Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 59.1M | 57.5M | 98.3M | 157.0M | 311.8M | 327.3M | |
Other Current Liab | 2.4M | 2.3M | 4.3M | (836K) | 27.0M | 28.4M | |
Total Current Liabilities | 12.3M | 10.8M | 9.7M | 18.6M | 49.3M | 51.8M | |
Total Stockholder Equity | 27.7M | 27.2M | 11.3M | 27.2M | 70.4M | 73.9M | |
Net Debt | 16.2M | 19.4M | 35.8M | 7.9M | 116.4M | 122.2M | |
Retained Earnings | (74.0M) | (77.4M) | (95.4M) | (109.5M) | (133.9M) | (127.2M) | |
Cash | 4.7M | 4.1M | 42.2M | 96.3M | 74.1M | 77.8M | |
Cash And Short Term Investments | 29.9M | 32.6M | 50.7M | 96.3M | 82.8M | 86.9M | |
Common Stock Shares Outstanding | 26.5M | 25.9M | 26.8M | 27.5M | 32.6M | 34.2M | |
Liabilities And Stockholders Equity | 59.1M | 57.5M | 98.3M | 157.0M | 311.8M | 327.3M | |
Other Stockholder Equity | 101.7M | 104.6M | 106.7M | 136.7M | 204.6M | 214.9M | |
Total Liab | 31.7M | 30.6M | 87.4M | 130.1M | 241.8M | 253.8M | |
Total Current Assets | 36.8M | 40.1M | 60.7M | 118.3M | 139.1M | 146.0M | |
Short Long Term Debt Total | 21.0M | 23.5M | 78.0M | 104.2M | 190.5M | 200.0M | |
Other Current Assets | 786K | 951K | 1.3M | 22.0M | 9.0M | 9.4M | |
Accounts Payable | 7.4M | 3.9M | 5.2M | 18.6M | 21.4M | 22.5M | |
Non Current Liabilities Total | 19.4M | 19.8M | 77.7M | 111.5M | 192.4M | 202.0M | |
Property Plant And Equipment Net | 11.9M | 11.3M | 9.1M | 11.0M | 12.4M | 13.1M | |
Non Current Assets Total | 22.3M | 17.3M | 37.7M | 37.2M | 172.7M | 181.3M | |
Property Plant And Equipment Gross | 11.9M | 11.3M | 16.9M | 20.1M | 20.4M | 21.4M | |
Long Term Debt | 12.2M | 12.4M | 71.7M | 104.2M | 183.2M | 192.3M | |
Net Tangible Assets | 25.0M | 24.9M | (6.2M) | 1.4M | 1.6M | 1.6M | |
Current Deferred Revenue | 57K | 66K | 16K | 113K | 75K | 71.3K | |
Retained Earnings Total Equity | (74.0M) | (77.4M) | (95.4M) | (109.5M) | (98.5M) | (103.5M) | |
Capital Surpluse | 101.7M | 104.6M | 106.7M | 137.1M | 157.6M | 85.0M | |
Short Term Debt | 2.4M | 4.5M | 280K | 723K | 806K | 765.7K | |
Non Currrent Assets Other | 7.7M | 3.8M | 12.4M | 2.0M | (2.1M) | (2.0M) | |
Accumulated Other Comprehensive Income | (2.8M) | (4.4M) | 0.0 | (409K) | (368.1K) | (386.5K) | |
Property Plant Equipment | 5.4M | 4.5M | 3.1M | 3.5M | 4.0M | 3.9M | |
Short Term Investments | 25.2M | 28.5M | 8.5M | 5.6M | 8.7M | 9.9M | |
Net Receivables | 2.7M | 2.7M | 4.5M | 6.4M | 36.5M | 38.3M | |
Long Term Debt Total | 12.2M | 12.4M | 71.7M | 104.2M | 119.8M | 125.8M | |
Capital Lease Obligations | 7M | 7.3M | 6.3M | 8.1M | 7.3M | 4.3M | |
Inventory | 3.3M | 4.0M | 4.2M | 6.5M | 10.9M | 11.4M | |
Non Current Liabilities Other | 7.2M | 7.5M | 6.0M | 7.3M | 8.4M | 8.9M | |
Intangible Assets | 2.3M | 1.9M | 17.1M | 25.8M | 162.0M | 170.1M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Harrow Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Harrow Health's short interest history, or implied volatility extrapolated from Harrow Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.75) | Revenue Per Share 3.992 | Quarterly Revenue Growth 0.788 | Return On Assets 0.0022 |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.